Skip to content

PRO-HAIR Study

Efficacy of Probiotics as an Adjunct to Standard Therapy in Androgenetic Alopecia(HAIR loss) : RCT (PRO- HAIR study ) - PRO-HAIR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/095497
Enrollment
120
Registered
2025-09-30
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Probiotics + Standard treatment (Hair transplant/medications: Will receive the same standard therapy as comparator group, along with a daily oral probiotic capsule for 16 weeks. The pro

Sponsors

All India Institute Of Medical Sciences Delhi Thesis grant
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adults aged 18 to 50 years with clinically diagnosed AGA (Hamilton Norwood scale for men, Ludwig scale for women). No antibiotic or probiotic use in the past month. Willingness to provide stool samples and adhere to study protocols.

Exclusion criteria

Exclusion criteria: Presence of other forms of alopecia (e.g., alopecia areata). Gastrointestinal disorders or systemic inflammatory conditions. Immunocompromised status or use of immunosuppressive medications.

Design outcomes

Primary

MeasureTime frame
Change in hair density measured objectively via standardized trichoscopic imaging and quantified using validated software-based analysis. Timepoint: 0,4 weeks,8 weeks,12 weeks and 16 weeks

Secondary

MeasureTime frame
Patient-reported outcomes on hair satisfaction and quality of life using Validated Questionnaire Assessment of gut microbiota composition through 16S rRNA sequencing of stool samples before the start of treatment and at 16 weeks after initiation of probiotic treatment. Bacterial 16S rRNA gene sequences (V3 V4 regions) will be amplified from the whole genome using the primers, 341F and 805R and amplicon libraries will be sequenced on an Illumina NovaSeq platform. Evaluation of systemic inflammatory markers and hormonal profiles Timepoint: 0, 16 weeks

Countries

India

Contacts

Public ContactDr Maneesh Singhal

AIIMS,Delhi

drmaneesh@gmail.com9810373345

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026